AACR Statement on Biden’s Cancer Diagnosis
PHILADELPHIA – The American Association for Cancer Research (AACR) today issued the following statement regarding former President Joseph R....
Search/Filter
Loading...
Incidence of Several Early-onset Cancers Increased Between 2010 and 2019
The largest increases were observed for breast, colorectal, endometrial, pancreatic, and kidney cancers PHILADELPHIA – In the United States,...
AACR Calls on Congress to Summarily Reject the President’s FY2026 Budget Proposal for NIH
The President’s FY2026 budget proposal includes devastating cuts to NIH of $18 billion, which would result in a nearly...
Cancer-related Fatigue and Depression May Lead to Decrease in Recreational Physical Activities and Quality of Life in Survivors
Female cancer survivors were 69% more likely to experience cancer-related fatigue and 58% more likely to experience depression than...
Patient Outcomes May Improve With Tailored Treatment Guided by Tissue Plus Liquid Biopsies vs. Individually
Treatment guided by both tests led to better outcomes than standard of care CHICAGO – Patients with advanced solid...
Breast Cancer Mortality in Women Ages 20-49 Significantly Dropped Between 2010 and 2020
CHICAGO – From 2010 to 2020, breast cancer deaths among women ages 20-49 declined significantly across all breast cancer...
Single-cell RNA Sequencing Provides Comprehensive Map of Acute Myeloid Leukemia Cell States
Study establishes a reference for normal hematopoietic cell differentiation and identifies novel acute myeloid leukemia cell states with potential...
American Association for Cancer Research Inaugurates New Leadership During AACR Annual Meeting 2025
Lillian L. Siu, MD, FAACR, begins term as AACR President CHICAGO – The members of the American Association for...
Oral HER2-targeted Therapy Zongertinib Demonstrates Clinical Benefit in Advanced HER2-mutated Lung Cancer
CHICAGO – Zongertinib, a human epidermal growth factor receptor 2 (HER2)-targeted tyrosine kinase inhibitor, elicited durable responses in patients...
A Liquid Biopsy-based Assay Could Detect Recurrence Prior to Imaging in Patients With Resectable Colorectal Cancer
CHICAGO – An ultrasensitive circulating tumor DNA (ctDNA)-based liquid biopsy assay detected signs of recurrence prior to imaging and...